Selank for Sleep Quality
Research, mechanism, dosing, and effectiveness of Selank for sleep quality.
Quick Answer
By reducing anxiety, Selank may improve sleep quality.
Evidence Level
Human Trials
Typical Dose
200 mcg in evening
Results Timeline
Sleep improvements within 1-2 weeks
FDA Status
Research Only
How Selank Works for Sleep Quality
GABA modulation supports relaxation.
About Sleep Quality
Improvement of sleep onset, duration, and overall sleep quality.
Research Evidence
Russian clinical trials demonstrate anxiolytic effects comparable to benzodiazepines without sedation or addiction potential. Studies show improved cognitive function under stress, enhanced memory, and stabilization of mood. Note: Selank was removed from FDA Category 2 in September 2024 when nominators withdrew the substance - now scheduled for PCAC review.
Dosing for Sleep Quality
Recommended Dose
200 mcg in evening
Frequency
2-3x daily, intranasal
Administration
Intranasal spray (most common), subcutaneous injection
Duration
14-21 days typical
Note: Anxiolytic nootropic. Used intranasally. Effects build over days/weeks. Often stacked with Semax.
What to Expect
Initial adjustment period. Some users may notice subtle changes.
Early benefits often become noticeable. Continue consistent use.
Most users report meaningful improvements by this point.
Full effects typically realized. Reassess and adjust as needed.
Possible Side Effects
Not everyone experiences these. Individual responses vary.
- •Generally well-tolerated
- •Nasal irritation (spray)
- •Headache
- •Nausea
- •Fatigue
- •Non-sedative and non-addictive
Frequently Asked Questions
Does Selank help with sleep quality?
By reducing anxiety, Selank may improve sleep quality.
How does Selank work for sleep quality?
GABA modulation supports relaxation....
What dose of Selank should I use for sleep quality?
200 mcg in evening
How long until I see results?
Sleep improvements within 1-2 weeks
Other Peptides for Sleep Quality
These peptides are also researched for sleep quality.
Semax
Clinical TrialsA synthetic peptide derived from ACTH (4-10) fragment with added Pro-Gly-Pro sequence. Approved in Russia for stroke and cognitive enhancement. Known for nootropic and neuroprotective effects.
Cerebrolysin
Clinical TrialsA mixture of low-molecular-weight neuropeptides derived from pig brain. Approved in many countries for stroke, traumatic brain injury, and dementia.
Dihexa
PreclinicalA potent cognitive-enhancing peptide derived from angiotensin IV. Reported to be 10 million times more potent than BDNF at promoting synaptogenesis.
GB-115
Clinical TrialsA dipeptide anxiolytic and nootropic that acts as a CCK-1 (cholecystokinin) receptor antagonist. Developed in Russia with completed Phase 3 trials for anxiety. Users report significant improvements in focus, attention, and ADHD-like symptoms.